Literature DB >> 11680691

Chondrocyte-derived ezrin-like domain containing protein (CDEP), a rho guanine nucleotide exchange factor, is inducible in chondrocytes by parathyroid hormone and cyclic AMP and has transforming activity in NIH3T3 cells.

Y Koyano1, T Kawamoto, A Kikuchi, M Shen, Y Kuruta, S Tsutsumi, K Fujimoto, M Noshiro, K Fujii, Y Kato.   

Abstract

OBJECTIVE: The purpose of this study is to investigate stage- and hormone-dependent expression of chondrocyte-derived ezrin-like domain containing protein (CDEP), a putative guanine nucleotide exchange factor (GEF) for Rho in chondrocytes, and demonstrate the guanine nucleotide exchange activity of this protein in vitro, as well as the transforming activity in NIH3T3 cells.
METHODS: The expression of CDEP mRNA in growth plate chondrocytes in vivo and in vitro was examined by RT-PCR Southern analysis. The guanine nucleotide exchange activity was determined using a recombinant CDEP peptide containing the DH and PH domains in Sf9 cell lysates. The transforming activity was examined using NIH3T3 cells transiently transfected with a truncated CDEP cDNA.
RESULTS: CDEP mRNA was expressed at the highest level in the hypertrophic (terminal) stage of chondrocytes in vivoand in vitro. Parathyroid hormone (PTH) elicited a biphasic increase of CDEP mRNA in chondrocytes. The CDEP mRNA level increased within 1 h, then decreased nearly to the control level at 3 h. Thereafter the mRNA level started to increase at 6 h, reaching a plateau at 24 h. Dibutyryl cyclic AMP had a similar effect on CDEP expression in chondrocytes. The dissociation of [3H]GDP from RhoA was stimulated dose-dependently by Sf9 cell lysates containing the CDEP peptide. Furthermore, transfection of a truncated CDEP cDNA induced focus formation in NIH3T3 cultures.
CONCLUSIONS: CDEP is a novel GEF for Rho family GTPases with the transforming activity. CDEP may play a role in mediating or modulating the action of cAMP-elevating hormones on maturing chondrocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11680691     DOI: 10.1053/joca.2001.0446

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  7 in total

Review 1.  Inhibition of Cdc42 and Rac1 activities in pheochromocytoma, the adrenal medulla tumor.

Authors:  Pauline Croisé; Laurent Brunaud; Petra Tóth; Stéphane Gasman; Stéphane Ory
Journal:  Small GTPases       Date:  2016-06-29

2.  ROCK2 inhibition triggers the collective invasion of colorectal adenocarcinomas.

Authors:  Fotine Libanje; Joel Raingeaud; Rui Luan; ZoéAp Thomas; Olivier Zajac; Joel Veiga; Laetitia Marisa; Julien Adam; Valerie Boige; David Malka; Diane Goéré; Alan Hall; Jean-Yves Soazec; Friedrich Prall; Maximiliano Gelli; Peggy Dartigues; Fanny Jaulin
Journal:  EMBO J       Date:  2019-06-18       Impact factor: 11.598

3.  Structural basis for autoinhibition of the guanine nucleotide exchange factor FARP2.

Authors:  Xiaojing He; Yi-Chun Kuo; Tyler J Rosche; Xuewu Zhang
Journal:  Structure       Date:  2013-01-31       Impact factor: 5.006

4.  A novel FERM domain including guanine nucleotide exchange factor is involved in Rac signaling and regulates neurite remodeling.

Authors:  Tateki Kubo; Toshihide Yamashita; Atsushi Yamaguchi; Hideki Sumimoto; Ko Hosokawa; Masaya Tohyama
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

5.  Androgen regulation of the human FERM domain encoding gene EHM2 in a cell model of steroid-induced differentiation.

Authors:  Sanjay Chauhan; Ritu Pandey; Jeffrey F Way; Thomas C Sroka; Manolis C Demetriou; Susan Kunz; Anne E Cress; David W Mount; Roger L Miesfeld
Journal:  Biochem Biophys Res Commun       Date:  2003-10-17       Impact factor: 3.575

6.  FARP1 boosts CDC42 activity from integrin αvβ5 signaling and correlates with poor prognosis of advanced gastric cancer.

Authors:  Takuro Hirano; Yoshinari Shinsato; Kan Tanabe; Nayuta Higa; Muhammad Kamil; Kohichi Kawahara; Masatatsu Yamamoto; Kentaro Minami; Michiko Shimokawa; Takaaki Arigami; Shigehiro Yanagita; Daisuke Matushita; Yoshikazu Uenosono; Sumiya Ishigami; Yuko Kijima; Kosei Maemura; Ikumi Kitazono; Akihide Tanimoto; Tatsuhiko Furukawa; Shoji Natsugoe
Journal:  Oncogenesis       Date:  2020-02-06       Impact factor: 7.485

7.  A CDC42-centered signaling unit is a dominant positive regulator of endothelial integrity.

Authors:  J Amado-Azevedo; N R Reinhard; J van Bezu; R X de Menezes; V W van Beusechem; G P van Nieuw Amerongen; V W M van Hinsbergh; P L Hordijk
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.